IA
RVMD icon

IFP Advisors’s Revolution Medicines RVMD Stock Holding History

IFP Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
745
+635
+577% +$92.8K ﹤0.01% 1750
2026
Q1 		$10.7K Buy
110
+95
+633% +$9.59K ﹤0.01% 3112
2025
Q4 		$1.2K Sell
15
-14
-48% -$918 ﹤0.01% 4014
2025
Q3 		$1.35K Sell
29
-369
-93% -$14.4K ﹤0.01% 3831
2025
Q2 		$15.4K Buy
398
+201
+102% +$7.72K ﹤0.01% 2685
2025
Q1 		$7.18K Sell
197
-579
-75% -$23.5K ﹤0.01% 2689
2024
Q4 		$34.2K Buy
+776
New +$39.2K ﹤0.01% 2018

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

IFP Advisors's RVMD Position: Q2 2026 in Review

IFP Advisors increased its Revolution Medicines (RVMD) stake by 577% in Q2 2026, buying an estimated $92.8K and bringing the position to 745 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

IFP Advisors first reported a position in RVMD in Q4 2024 and has held it in 7 quarters since. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • IFP Advisors held 745 shares of Revolution Medicines worth $140K as of Q2 2026.
  • IFP Advisors bought 635 Revolution Medicines shares in Q2 2026, an estimated $92.8K.
  • Revolution Medicines made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1750 holding.
  • IFP Advisors first reported a position in Revolution Medicines in Q4 2024 and has held it in 7 quarters since.
  • 692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.